Delivery Order SPE2DB22D9247-SPE2DB24FS2EU
Award Date 3/20/24
Potential Completion Date 4/10/24
Potential Value $5.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $5,537.76, is for the delivery of 100 unit vials of BOTOX to fulfill the recurring pharmaceutical needs of military health facilities supported by DLA worldwide. This delivery order is part of a larger indefinite delivery contract, valued up to $4,999,999, that enables DLA...
- This is a $23,074 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the supply of 100-unit vials of the drug BOTOX. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue orders for a comprehensive range of pharmaceutical products to support the medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $13,704 contract is for the delivery of 100-unit BOTOX vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,836.20 contract is for the delivery of 200-unit vials of Botox medication to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,481.60 delivery order is for 100-unit vials of Botox, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC enables...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 100-unit vials of BOTOX with a potential value of $2,768.88. This order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to supply a variety of pharmaceutical and medical products in support of military treatment facilities worldwide. The contract does not have a set-aside designation, and the delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,537.76 contract is to provide BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,625.70, is for the delivery of BOTOX 100 UNIT VIALS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $4,614.80 contract is for the delivery of 100-unit vials of Botox to support military treatment facilities. The order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to provide a variety of pharmaceutical and medical supplies, with a potential value up to $5 million through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $48,455.40, is for the delivery of 4,565,988,703 vials of Botox 100 unit injections. The period of performance runs through October 21, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- SPE2DB22D9247Indefinite Delivery Contract
- SPE2DB22D9247-SPE2DB24FS2EUDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,537.76 contract is for the delivery of BOTOX 100 UNIT VIALS to fulfill the recurring pharmaceutical supply needs of military health facilities supported by DLA worldwide. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with DLA, valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, epinephrine auto-injectors, and contraceptive products. This delivery order does not have a set-aside designation.
Generated 6/19/24, 9:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 3/20/24 |